126 related articles for article (PubMed ID: 20372822)
1. Analysis of expression and structure of the TSG101 gene in cervical cancer cells.
Broniarczyk J; Olejnik-Schmidt AK; Luczak MW; Schmidt MT; Dabrowski M; Józefiak A; Kedzia W; Kwasniewska A; Gozdzicka-Józefiak A
Int J Mol Med; 2010 May; 25(5):777-83. PubMed ID: 20372822
[TBL] [Abstract][Full Text] [Related]
2. TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.
Chua HH; Huang CS; Weng PL; Yeh TH
Oncotarget; 2016 Feb; 7(7):8240-52. PubMed ID: 26811492
[TBL] [Abstract][Full Text] [Related]
3. Identification of TSG101 functional domains and p21 loci required for TSG101-mediated p21 gene regulation.
Lin YS; Chen YJ; Cohen SN; Cheng TH
PLoS One; 2013; 8(11):e79674. PubMed ID: 24244542
[TBL] [Abstract][Full Text] [Related]
4. TSG101, identified by screening a cancer cDNA library and soft agar assay, promotes cell proliferation in human lung cancer.
Liu F; Yu Y; Jin Y; Fu S
Mol Biol Rep; 2010 Jul; 37(6):2829-38. PubMed ID: 19787439
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection requires the TSG101 component of the ESCRT machinery.
Broniarczyk J; Bergant M; Goździcka-Józefiak A; Banks L
Virology; 2014 Jul; 460-461():83-90. PubMed ID: 25010273
[TBL] [Abstract][Full Text] [Related]
6. TSG101, a tumor susceptibility gene, bidirectionally modulates cell invasion through regulating MMP-9 mRNA expression.
Sai XB; Makiyama T; Sakane H; Horii Y; Hiraishi H; Shirataki H
BMC Cancer; 2015 Nov; 15():933. PubMed ID: 26608825
[TBL] [Abstract][Full Text] [Related]
7. An upstream regulatory element confers orientation-independent enhancement of the TSG101 promoter activity in transformed cells.
Hsu SF; Goan YG; Tsai HY; Lin YR; Liu RT; Cheng JT
Mol Biol Rep; 2012 Jan; 39(1):517-25. PubMed ID: 21556761
[TBL] [Abstract][Full Text] [Related]
8. TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation.
Lu Q; Hope LW; Brasch M; Reinhard C; Cohen SN
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7626-31. PubMed ID: 12802020
[TBL] [Abstract][Full Text] [Related]
9. [HIV-1 infection affects the expression of host cell factor TSG101 and Alix].
Hu HL; Meng ZF; Zhang XY; Lu JX
Bing Du Xue Bao; 2011 Mar; 27(2):129-34. PubMed ID: 21528537
[TBL] [Abstract][Full Text] [Related]
10. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of aberrant TSG101 transcripts in acute myeloblastic leukemia.
Lin SF; Lin PM; Liu TC; Chang JG; Sue YC; Chen TP
Leuk Lymphoma; 2000 Feb; 36(5-6):463-6. PubMed ID: 10784390
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.
Liu RT; Huang CC; You HL; Chou FF; Hu CC; Chao FP; Chen CM; Cheng JT
Oncogene; 2002 Jul; 21(31):4830-7. PubMed ID: 12101421
[TBL] [Abstract][Full Text] [Related]
13. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
14. TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence.
Feng GH; Lih CJ; Cohen SN
Cancer Res; 2000 Mar; 60(6):1736-41. PubMed ID: 10749147
[TBL] [Abstract][Full Text] [Related]
15. Role of TSG101 in uterine cervix cancer.
O'Boyle JD; Proctor ML; Fong KM; Lin WM; Miller DS; Muller CY
Gynecol Oncol; 1999 Dec; 75(3):401-5. PubMed ID: 10600297
[TBL] [Abstract][Full Text] [Related]
16. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.
Li L; Cohen SN
Cell; 1996 May; 85(3):319-29. PubMed ID: 8616888
[TBL] [Abstract][Full Text] [Related]
17. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
[TBL] [Abstract][Full Text] [Related]
18. Significant increase of a specific variant TSG101 transcript during the progression of cervical neoplasia.
Klaes R; Kloor M; Willeke F; Melsheimer P; von Knebel Doeberitz M; Ridder R
Eur J Cancer; 1999 May; 35(5):733-7. PubMed ID: 10505033
[TBL] [Abstract][Full Text] [Related]
19. TSG101 interacts with the androgen receptor and attenuates its expression through the endosome/lysosome pathway.
Lin YM; Chu PH; Ouyang P
Biochem Biophys Res Commun; 2018 Sep; 503(1):157-164. PubMed ID: 29859188
[TBL] [Abstract][Full Text] [Related]
20. TSG101 Silencing Suppresses Hepatocellular Carcinoma Cell Growth by Inducing Cell Cycle Arrest and Autophagic Cell Death.
Shao Z; Ji W; Liu A; Qin A; Shen L; Li G; Zhou Y; Hu X; Yu E; Jin G
Med Sci Monit; 2015 Nov; 21():3371-9. PubMed ID: 26537625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
